Clinical Trials Logo

Acromegaly Due to Pituitary Adenoma clinical trials

View clinical trials related to Acromegaly Due to Pituitary Adenoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT03807076 Recruiting - Clinical trials for Acromegaly Due to Pituitary Adenoma

Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

GA-9
Start date: August 13, 2019
Phase: N/A
Study type: Interventional

Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma

NCT ID: NCT03439709 Not yet recruiting - Clinical trials for Acromegaly Due to Pituitary Adenoma

Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma

MERGE
Start date: March 1, 2018
Phase: Phase 3
Study type: Interventional

In this study, the investigators hypothesize that upfront gamma knife radiosurgery with drug therapy is superior in the treatment of growth hormone-secreting pituitary tumors after primary surgical treatment compared with the drug therapy alone. This study can provide useful clinical information in the treatment of patients with acromegaly.